Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome

Hepatology

Volumn 43, Issue 1, 2006, Pages 27-33

  Hernández Guerra, Manuel ^a   López, Eric ^a   Bellot, Pablo ^a   Piera, Carlos ^a   Turnes, Juan ^a   Abraldes, Juan G ^a   Bosch, Jaime ^a   García Pagán, Juan C ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; NORADRENALIN;

ADULT; ARTICLE; BODY SURFACE; BUDD CHIARI SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART HEMODYNAMICS; HEART INDEX; HUMAN; LABORATORY TEST; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; PLASMA RENIN ACTIVITY; PLASMA VOLUME; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION; AGED; HEART OUTPUT; HEMATOCRIT; HEMODYNAMICS; LIVER VEIN THROMBOSIS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PORTOSYSTEMIC ANASTOMOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR RESISTANCE;

ADULT; AGED; CARDIAC OUTPUT; FEMALE; HEMATOCRIT; HEMODYNAMIC PROCESSES; HEPATIC VEIN THROMBOSIS; HUMANS; MALE; MIDDLE AGED; PLASMA VOLUME; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RENIN-ANGIOTENSIN SYSTEM; VASCULAR RESISTANCE;

EID: 33644807095     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20990     Document Type: Article

References (34)

1. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003;38:364-371.
2. Perello A, Garcia-Pagan JC, Gilabert R, Suarez Y, Moitinho E, Cervantes F, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. HEPATOLOGY 2002;35:132-139.
3. Hernandez-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, et al. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. HEPATOLOGY 2004;40:1197-1202.
4. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. HEPATOLOGY 1988;8:1151-1157.
5. Kotelanski B, Groszmann R, Cohn JN. Circulation times in the splanchnic and hepatic beds in alcoholic liver disease. Gastroenterology 1972;63:102-111.
6. Bosch J, Arroyo V, Betriu A, Mas A, Carrilho F, Rivera F, et al. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology 1980;78:92-99.
7. Albillos A, Colombato LA, Groszmann RJ. Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology 1992;102:931-935.
8. Espinosa G, Font J, Garcia-Pagan JC, Tassies D, Reverter JC, Gaig C, et al. Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients. Medicine (Baltimore) 2001;80:345-354.
9. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
10. Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. HEPATOLOGY 1999;30:84-89.
11. Murad SD, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. HEPATOLOGY 2004;39:500-508.
12. Asbert M, Jimenez W, Gaya J, Gines P, Arroyo V, Rivera F, et al. Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin. J Hepatol 1992;15:179-183.
13. Salo J, Gines A, Gines P, Piera C, Jimenez W, Guevara M, et al. Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis. J Hepatol 1997;27:645-653.
14. Recommended methods for measurement of red-cell and plasma volume: International Committee for Standardization in Haematology. J Nucl Med 1980;21:793-800.
15. Pearson TC, Messinezy M, Westwood N, Green AR, Bench AJ, Green AR, et al. A Polycythemia Vera Updated: Diagnosis, Pathobiology, and Treatment. Hematology (Am Soc Hematol Educ Program ) 2000:51-68.
16. Lieberman FL, Reynolds TB. Plasma volume in cirrhosis of the liver: its relation to portal hypertension, ascites and renal failure. J Clin Invest 1967;46:1297-1308.
17. Lebrec D, Bataille C, Bercoff E, Valla D. Hemodynamic changes in patients with portal venous obstruction. HEPATOLOGY 1983;3:550-553.
18. Braillon A, Moreau R, Hadengue A, Roulot D, Sayegh R, Lebrec D. Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension. Effect of propranolol. J Hepatol 1989;9:312-318.
19. Beattie C, Sitzmann JV, Cameron JL. Mesoatrial shunt hemodynamics. Surgery 1988;104:1-9.
20. Tsai MH, Iwakiri Y, Cadelina G, Sessa WC, Groszmann RJ. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats. Gastroenterology 2003;125:1452-1461.
21. Henriksen JH, Bendtsen F, Moller S. Normal red cell cardiac output in the hyperkinetic syndrome of alcoholic cirrhosis. J Hepatol 2001;34:782-783.
22. Kostreva DR, Castaner A, Kampine JP. Reflex effects of hepatic baroreceptors on renal and cardiac sympathetic nerve activity. Am J Physiol 1980;238:R390-R394.
23. Orloff MJ, Rooss TH, Baddeley R, Nutting R, Spitz B, Sloop R, et al. Experimental ascites. VI. The effects of hepatic venous outflow obstruction and ascites on aldosterone secretion. Surgery 1964;56:83-98.
24. Levy M. Renal function in dogs with acute selective hepatic venous outflow block. Am J Physiol 1974;227:1074-1083.
25. Blanchart A, Rodriguez-Puyol D, Santos JC, Hernando L, Lopez-Novoa JM. Effect of chronic and progressive hepatic outflow blockade on renal function in rats. J Lab Clin Med 1987;109:718-723.
26. Jalan R, Forrest EH, Redhead DN, Dillon JF, Hayes PC. Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut 1997;40:664-670.
27. Colombato LA, Albillos A, Groszmann RJ. The role of central blood volume in the development of sodium retention in portal hypertensive rats. Gastroenterology 1996;110:193-198.
28. Hadengue A, Moreau R, Gaudin C, Bacq Y, Champigneulle B, Lebrec D. Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion. HEPATOLOGY 1992;15:809-815.
29. Andreu V, Perello A, Moitinho E, Escorsell A, Garcia-Pagan JC, Bosch J, et al. Total effective vascular compliance in patients with cirrhosis. Effects of propranolol. J Hepatol 2002;36:356-361.
30. Elizalde JI, Moitinho E, Garcia-Pagan JC, Cirera I, Escorsell A, Bandi JC, et al. Effects of increasing blood hemoglobin levels on systemic hemodynamics of acutely anemic cirrhotic patients. J Hepatol 1998;29:789-795.
31. Luca A, Cirera I, Garcia-Pagan JC, Feu F, Pizcueta P, Bosch J, et al. Hemodynamic effects of acute changes in intra-abdominal pressure in patients with cirrhosis. Gastroenterology 1993;104:222-227.
32. Luca A, Feu F, Garcia-Pagan JC, Jimenez W, Arroyo V, Bosch J, et al. Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites. HEPATOLOGY 1994;20:30-33.
33. Bargallo X, Gilabert R, Nicolau C, Garcia-Pagan JC, Bosch J, Bru C. Sonography of the caudate vein: value in diagnosing Budd-Chiari syndrome. AJR Am J Roentgenol 2003;181:1641-1645.
34. Naeije R. Pulmonary vascular function. In: Peacock AJ, Rubin LJ, eds. Pulmonary Circulation: Diseases and Their Treatment. 2nd ed. London: Oxford University Press, 2005:3-11.